Then, we performed a CCK‐8 assay, which showed that compared with the Lv‐MEF2A group, RCC cells had increased cell proliferation ability in the Lv‐MEF2A + CHIR group (Figure 7A). This evidence concerns the gene MEF2A and renal cell carcinoma.